Network-based approach to identify biomarkers predicting response and prognosis for HER2-negative breast cancer treatment with taxane-anthracycline neoadjuvant chemotherapyCui Jiang, Tao Sun, Na Li et al.|PeerJ|2019Cited by 18
Combined use of apatinib mesylate and vinorelbine versus vinorelbine alone in recurrent or metastatic triple-negative breast cancer: study protocol for a randomized controlled clinical trialShuo Wu, Tao Sun, Junnan Xu et al.|Trials|2020Cited by 10
Combined use of apatinib mesylate and vinorelbine versus vinorelbine alone in recurrent or metastatic triple-negative breast cancer: study protocol for a randomized controlled clinical trialShuo Wu, Tao Sun, Junnan Xu et al.|Research Square|2020Cited by 1